Skip to main content

Advertisement

SpringerLink
Log in

Chemotherapy-induced sclerosing cholangitis as a rare indication for resection: Report of a case

  • Case Report
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

Bile duct stricture due to chemotherapy-induced sclerosing cholangitis (CISC) is a potentially fatal complication of hepatic arterial infusion chemotherapy (HAIC). It is managed primarily with medical treatment and biliary stenting. We report a rare case of a CISC-related biliary stricture requiring resection. The patient had been receiving adjuvant HAIC for 11 months after a curative liver resection for hepatocellular carcinoma, when clinically overt cholangitis developed. Radiologic and biopsy findings suggested a CISC-related biliary stricture limited to the common hepatic duct. We discontinued HAIC and started corticosteroid treatment, which finally became ineffective. Endoscopic biliary stenting was impossible because of her severe biliary sclerosis, necessitating resection of the stricture, which was confirmed histologically to be secondary sclerosing cholangitis. The patient has shown no signs of recurrent cholangitis for 12 postoperative months since her operation. Thus, resection could be a treatment option for a CISC-related biliary stricture in selected patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Botet JF, Watson RC, Kemeny N, Daly JM, Yeh S. Cholangitis complicating intraarterial chemotherapy in liver metastasis. Radiology 1985;156:335–337.

    PubMed  CAS  Google Scholar 

  2. Hohn D, Melnick J, Stagg R, Altman D, Friedman M, Ignoffo R, et al. Biliary sclerosis in patients receiving hepatic arterial infusions of floxuridine. J Clin Oncol 1985;3:98–102.

    PubMed  CAS  Google Scholar 

  3. Kemeny MM, Battifora H, Blayney DW, Cecchi G, Goldberg DA, Leong LA, et al. Sclerosing cholangitis after continuous hepatic artery infusion of FUDR. Ann Surg 1985;202:176–181.

    Article  PubMed  CAS  Google Scholar 

  4. Pozniak MA, Babel SG, Trump DL. Complications of hepatic arterial infusion chemotherapy. Radiographics 1991;11:67–79.

    PubMed  CAS  Google Scholar 

  5. Rougier P, Laplanche A, Huguier M, Hay JM, Ollivier JM, Escat J, et al. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial. J Clin Oncol 1992;10:1112–1118.

    PubMed  CAS  Google Scholar 

  6. Aldrighetti L, Arru M, Ronzoni M, Salvioni M, Villa E, Ferla G. Extrahepatic biliary stenoses after hepatic arterial infusion (HAI) of floxuridine (FUdR) for liver metastases from colorectal cancer. Hepatogastroenterology 2001;48:1302–1307.

    PubMed  CAS  Google Scholar 

  7. Barnett KT, Malafa MP. Complications of hepatic artery infusion: a review of 4580 reported cases. Int J Gastrointest Cancer 2001;30:147–160.

    Article  PubMed  CAS  Google Scholar 

  8. Ludwig J, Kim CH, Wiesner RH, Krom RA. Floxuridine-induced sclerosing cholangitis: an ischemic cholangiopathy? Hepatology 1989;9:215–218.

    Article  PubMed  CAS  Google Scholar 

  9. Batts KP. Ischemic cholangitis. Mayo Clin Proc 1998;73:380–385.

    Article  PubMed  CAS  Google Scholar 

  10. Geubel AP, Sempoux C, Rahier J. Bile duct disorders. Clin Liver Dis 2003;7:295–309.

    Article  PubMed  Google Scholar 

  11. Fukuzumi S, Moriya Y, Makuuchi M, Terui S. Serious chemical sclerosing cholangitis associated with hepatic arterial 5FU and MMC chemotherapy. Eur J Surg Oncol 1990;16:251–255.

    PubMed  CAS  Google Scholar 

  12. Moriya Y, Sugihara K, Hojo K, Makuuchi M. Adjuvant hepatic intra-arterial chemotherapy after potentially curative hepatectomy for liver metastases from colorectal cancer: a pilot study. Eur J Surg Oncol 1991;17:519–525.

    PubMed  CAS  Google Scholar 

  13. Kemeny N, Seiter K, Niedzwiecki D, Chapman D, Sigurdson E, Cohen A, et al. A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer. Cancer 1992;69:327–334.

    Article  PubMed  CAS  Google Scholar 

  14. Campos LT. A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer. Cancer 1993;71:875–876.

    Article  PubMed  CAS  Google Scholar 

  15. Alazmi WM, McHenry L, Watkins JL, Fogel EL, Schmidt S, Sherman S, et al. Chemotherapy-induced sclerosing cholangitis: long-term response to endoscopic therapy. J Clin Gastroenterol 2006;40:353–357.

    Article  PubMed  Google Scholar 

  16. Sandrasegaran K, Alazmi WM, Tann M, Fogel EL, McHenry L, Lehman GA. Chemotherapy-induced sclerosing cholangitis. Clin Radiol 2006;61:670–678.

    Article  PubMed  CAS  Google Scholar 

  17. Phongkitkarun S, Kobayashi S, Varavithya V, Huang X, Curley SA, Charnsangavej C. Bile duct complications of hepatic arterial infusion chemotherapy evaluated by helical CT. Clin Radiol 2005;60:700–709.

    Article  PubMed  CAS  Google Scholar 

  18. Shea WJ Jr, Demas BE, Goldberg HI, Hohn DC, Ferrell LD, Kerlan RK. Sclerosing cholangitis associated with hepatic arterial FUDR chemotherapy: radiographic-histologic correlation. Am J Roentgenol 1986;146:717–721.

    Google Scholar 

  19. Kouraklis G. A gallbladder conduit for bile duct reconstruction to treat benign biliary stenosis. Surg Today 2006;36:761–763.

    Article  PubMed  Google Scholar 

  20. Guckelberger O, Stange B, Glanemann M, Lopez-Hanninen E, Heidenhain C, Jonas S, et al. Hepatic resection in liver transplant recipients: single center experience and review of the literature. Am J Transplant 2005;5:2403–2409.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, International University of Health and Welfare, Mita Hospital, 1-4-3 Mita, Minato-ku, Tokyo, 108-8329, Japan

    Yutaro Kato, Ayu Kato, Yoshiaki Sugiura & Masaki Kitajima

  2. Department of Surgery, KKR Tachikawa Hospital, Tokyo, Japan

    Kentaro Matsubara, Yoshinobu Akiyama, Hiroaki Hattori, Akira Hirata, Fumio Suzuki & Hitoshi Ohtaka

Authors
  1. Yutaro Kato
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kentaro Matsubara
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yoshinobu Akiyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hiroaki Hattori
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Akira Hirata
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Fumio Suzuki
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hitoshi Ohtaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ayu Kato
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Yoshiaki Sugiura
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Masaki Kitajima
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kato, Y., Matsubara, K., Akiyama, Y. et al. Chemotherapy-induced sclerosing cholangitis as a rare indication for resection: Report of a case. Surg Today 39, 905–908 (2009). https://doi.org/10.1007/s00595-008-3943-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00595-008-3943-z

Key words

Search

Navigation